期刊文献+

选择性PDGFR抑制剂CP-673451对A549细胞侵袭和迁移的抑制作用

CP-673451,a Selective PDGFR Inhibitor,Suppressing A549 Cells Invasion and Migration
下载PDF
导出
摘要 目的探讨选择性PDGFR抑制剂CP-673451对人非小细胞肺癌(NSCLC)细胞增殖、侵袭、迁移的影响及其作用机制。方法体外培养人非小细胞肺癌A549细胞,采用Transwell法、划痕法和免疫荧光法检测细胞侵袭、迁移和片状伪足形成的影响,Western印迹实验检测A549细胞的Akt、GSK-3β、p70S6和S6蛋白的磷酸化水平。结果CP-673451能够抑制A549细胞侵袭、迁移和伪足形成,抑制Akt、GSK-3β、p70S6和S6蛋白的磷酸化,且呈浓度依赖性。结论CP-673451抑制人非小细胞肺癌细胞侵袭和迁移,抑制PDGFR下游信号传导通路蛋白的表达,可能是其作用机制。 Objective To investigate the effects of selective PDGFR inhibitor CP-673451 on proliferation,invasion and migration of human non-small cell lung cancer(NSCLC)cells and its mechanism.Methods Human non-small cell lung cancer A549 cells were cultured in vitro.Cell invasion,migration and sheet pseudopod formation were detected by using the Transvel methode,the scratch and the immunofluorescence experiments.The phosphorylation levels of Akt,GSK-3β,p70S6 and S6 proteins were detected by using Western blotting.Results CP-673451 inhibited A549 cells of invasion,migration and pseudopod formation,and the phosphorylated of Akt,GSK-3β,p70S6 and S6 in a concentration-dependent manner.Conclusion CP-673451 inhibits the invasion and migration of human non-small cell lung cancer cells,and may suppress the expression of downstream signaling transduction pathway proteins of PDGFR,which may be the potential mechanism.
作者 平贯芳 郗玉玲 邓智建 PING Guan-fang;XI Yu-ling;DENG Zhi-jian(Department of Clinical Pharmacy,the First Affiliated Hospital of XinxiangMedical University,Xinxiang 453100,China)
出处 《河南科技大学学报(医学版)》 2019年第3期173-176,共4页 Journal of Henan University of Science & Technology:Medical Science
基金 河南省医学科技攻关项目(201702129)
关键词 非小细胞肺癌 CP-673451 细胞侵袭 细胞迁移 non-small cell lung cancer CP-673451 cell invasion cell migration
  • 相关文献

参考文献4

二级参考文献54

  • 1罗锦辉,唐建武.PDGF-B、PDGFR-α在小细胞肺癌中的不同表达[J].肿瘤,2004,24(5):476-477. 被引量:12
  • 2Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev, 2004, 15(4): 197-204.
  • 3Yu J, Ustach C, Kim HR. Platelet-derived growth factor signaling and human cancer.J Biochem Mol Biol, 2003, 36(1): 49-59.
  • 4Heldin CH. Autocrine PDGF stimulation in malignancies. Ups J Med Sci, 2012, 117(2): 83-91.
  • 5Wu Q., Hou X, Xia J, et al. Emerging roles of PDGF-D in EMT progression during tumorigenesis. Cancer Treat Rev, 2013, 39(6): 640-646.
  • 6Hermanson M, Funa K, Hartman M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res, 1992, 52(11): 3213-3219.
  • 7Vignaud JM, Marie B, Klein N, et al. The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. Cancer Res, 1994, 54(20): 5455-5463.
  • 8Tsao AS, Wei W, Kuhn E, et al. Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-celllung cancer. Clin Lung Cancer, 2011, 12(6): 369-374.
  • 9Bremnes RM, Donnem T, Al-Saad S, et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol, 2011, 6(1): 209-217.
  • 10Petrillo M, Scambia G, Ferrandina G. Novel targets for VEGF- independent anti-angiogenic drugs. Expert Opin Investig Drugs, 2012, 21(4): 451-472.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部